Sutherland RL - Search Results

1

High Notch1 protein expression is an early event in breast cancer development and is associated with the HER-2 molecular subtype.

Zardawi SJ, Zardawi I, McNeil CM, Millar EK, McLeod D, Morey AL, Crea P, Murphy NC, Pinese M, Lopez-Knowles E, Oakes SR, Ormandy CJ, Qiu MR, Hamilton A, Spillane A, Soon Lee C, Sutherland RL, Musgrove EA, O'Toole SA. Zardawi SJ, et al. Among authors: sutherland rl. Histopathology. 2010 Feb;56(3):286-96. doi: 10.1111/j.1365-2559.2009.03475.x. Histopathology. 2010. PMID: 20459529

2

Cyclins and breast cancer.

Sutherland RL, Musgrove EA. Sutherland RL, et al. J Mammary Gland Biol Neoplasia. 2004 Jan;9(1):95-104. doi: 10.1023/B:JOMG.0000023591.45568.77. J Mammary Gland Biol Neoplasia. 2004. PMID: 15082921 Review.

3

Live or let die: oestrogen regulation of survival signalling in endocrine response.

Butt AJ, Sutherland RL, Musgrove EA. Butt AJ, et al. Among authors: sutherland rl. Breast Cancer Res. 2007;9(5):306. doi: 10.1186/bcr1779. Breast Cancer Res. 2007. PMID: 17980055 Free PMC article. Review.

4

Dysregulation of Hedgehog, Wnt and Notch signalling pathways in breast cancer.

Zardawi SJ, O'Toole SA, Sutherland RL, Musgrove EA. Zardawi SJ, et al. Among authors: sutherland rl. Histol Histopathol. 2009 Mar;24(3):385-98. doi: 10.14670/HH-24.385. Histol Histopathol. 2009. PMID: 19130408 Review.

5

The Hedgehog signalling pathway as a therapeutic target in early breast cancer development.

O'Toole SA, Swarbrick A, Sutherland RL. O'Toole SA, et al. Among authors: sutherland rl. Expert Opin Ther Targets. 2009 Sep;13(9):1095-103. doi: 10.1517/14728220903130612. Expert Opin Ther Targets. 2009. PMID: 19659449 Review.

6

Loss of STARD10 expression identifies a group of poor prognosis breast cancers independent of HER2/Neu and triple negative status.

Murphy NC, Biankin AV, Millar EK, McNeil CM, O'Toole SA, Segara D, Crea P, Olayioye MA, Lee CS, Fox SB, Morey AL, Christie M, Musgrove EA, Daly RJ, Lindeman GJ, Henshall SM, Visvader JE, Sutherland RL. Murphy NC, et al. Among authors: sutherland rl. Int J Cancer. 2010 Mar 15;126(6):1445-53. doi: 10.1002/ijc.24826. Int J Cancer. 2010. PMID: 19676041

7

PI3K pathway activation in breast cancer is associated with the basal-like phenotype and cancer-specific mortality.

López-Knowles E, O'Toole SA, McNeil CM, Millar EK, Qiu MR, Crea P, Daly RJ, Musgrove EA, Sutherland RL. López-Knowles E, et al. Among authors: sutherland rl. Int J Cancer. 2010 Mar 1;126(5):1121-31. doi: 10.1002/ijc.24831. Int J Cancer. 2010. PMID: 19685490

8

Biological determinants of endocrine resistance in breast cancer.

Musgrove EA, Sutherland RL. Musgrove EA, et al. Among authors: sutherland rl. Nat Rev Cancer. 2009 Sep;9(9):631-43. doi: 10.1038/nrc2713. Nat Rev Cancer. 2009. PMID: 19701242 Review.

9

Cytoplasmic localization of beta-catenin is a marker of poor outcome in breast cancer patients.

López-Knowles E, Zardawi SJ, McNeil CM, Millar EK, Crea P, Musgrove EA, Sutherland RL, O'Toole SA. López-Knowles E, et al. Among authors: sutherland rl. Cancer Epidemiol Biomarkers Prev. 2010 Jan;19(1):301-9. doi: 10.1158/1055-9965.EPI-09-0741. Cancer Epidemiol Biomarkers Prev. 2010. PMID: 20056651

10

Overexpression of the oncogenic signal transducer Gab2 occurs early in breast cancer development.

Fleuren ED, O'Toole S, Millar EK, McNeil C, Lopez-Knowles E, Boulghourjian A, Croucher DR, Schramek D, Brummer T, Penninger JM, Sutherland RL, Daly RJ. Fleuren ED, et al. Among authors: sutherland rl. Int J Cancer. 2010 Sep 1;127(6):1486-92. doi: 10.1002/ijc.25172. Int J Cancer. 2010. PMID: 20087860

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

391 results

Search Page

Filters